Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ATHENAHEALTH INC
Report date February 11, 2019 · Filed February 13, 2019
Section 16 reporting ended · disclosed 2019-02-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-11 transaction · row 1
1 source rowRow 1 · 2019-02-11 · Disposition to issuer · Disposed 15,527 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2: 7,189 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration, subject to any required withholding taxes. F3: Amount includes 7,176 shares of Common Stock underlying performance stock unit ("PSU") awards which had not been previously reported. Pursuant to the Merger Agreement, on February 11, 2019, each PSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive the Merger Consideration (as if the applicable performance conditions were deemed achieved at such levels as described in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.
F2: 7,189 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration, subject to any required withholding taxes.
F3: Amount includes 7,176 shares of Common Stock underlying performance stock unit ("PSU") awards which had not been previously reported. Pursuant to the Merger Agreement, on February 11, 2019, each PSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive the Merger Consideration (as if the applicable performance conditions were deemed achieved at such levels as described in the Merger Agreement).
Sprinklr, Inc.
Report date March 15, 2023 · Filed March 18, 2023
Section 16 reporting ended · disclosed 2023-03-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 101,544 |
Reported balance
After 2023-03-15 transaction · row 1
1 source rowRow 1 · 2023-03-15 · Conversion · Acquired 1,000 · Balance 101,544 F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. Each share of Class B Common Stock will convert automatically into shares of Class A common stock, on a one-to-one basis, upon the following: (1) the sale or transfer of such share of Class B Common Stock, subject to certain exceptions specified in the Issuer's amended and restated certificate of incorporation; (2) the death of the Reporting Person; and (3) the final conversion date, defined as the first trading day on or after the date on which the outstanding shares of Class B Common Stock represent less than 5.0% of the Issuer's then-outstanding Class A and Class B Common Stock, subject to certain timing criteria. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 140,291 |
Reported balance
After 2023-03-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-15 · Conversion · Disposed 1,000 · Balance 140,291 F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. Each share of Class B Common Stock will convert automatically into shares of Class A common stock, on a one-to-one basis, upon the following: (1) the sale or transfer of such share of Class B Common Stock, subject to certain exceptions specified in the Issuer's amended and restated certificate of incorporation; (2) the death of the Reporting Person; and (3) the final conversion date, defined as the first trading day on or after the date on which the outstanding shares of Class B Common Stock represent less than 5.0% of the Issuer's then-outstanding Class A and Class B Common Stock, subject to certain timing criteria. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. Each share of Class B Common Stock will convert automatically into shares of Class A common stock, on a one-to-one basis, upon the following: (1) the sale or transfer of such share of Class B Common Stock, subject to certain exceptions specified in the Issuer's amended and restated certificate of incorporation; (2) the death of the Reporting Person; and (3) the final conversion date, defined as the first trading day on or after the date on which the outstanding shares of Class B Common Stock represent less than 5.0% of the Issuer's then-outstanding Class A and Class B Common Stock, subject to certain timing criteria.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2021 Filed Jun 24, 2021 23:11 UTC | Sprinklr, Inc. CXM · Entity 4581 | GrantCommon Stock | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043146 · doc4.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · General Counsel and Corp. Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,291 F1 · shares: 20,000 shares represent a restricted stock unit ("RSU") award. One fifth (1/5th) of the RSUs shall vest on January 28, 2022, and one sixteenth (1/16th) of the remaining RSUs shall vest every three (3) months thereafter. 120,000 shares represent a performance stock unit ("PSU") award. The PSUs vest upon both the achievement of certain stock prices and the passage of time. 40,000 PSUs shall vest upon the Issuer's Class A Common Stock trading at each of $30, $40 and $50, as measured on a 45 day weighted average trading price and one fifth (1/5th) of the PSUs (that meet the stock price achievement) shall vest on January 28, 2022, and one sixteenth (1/16th) of the remaining PSUs shall vest every three (3) months thereafter. The vesting of the RSUs and PSUs are subject to the Reporting Person's continuous service. F2 · shares: Each share of Common Stock shall be reclassified into one share of Class B Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. F2 · balance_after: Each share of Common Stock shall be reclassified into one share of Class B Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 18:18 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Disposition to issuerCommon Stock | 15,527 | $135.00 | $2,096,145.00 |
DisclosureSEC source: 0001131096-19-000030 · wf-form4_155009988861635.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2 · shares: 7,189 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration, subject to any required withholding taxes. F3 · shares: Amount includes 7,176 shares of Common Stock underlying performance stock unit ("PSU") awards which had not been previously reported. Pursuant to the Merger Agreement, on February 11, 2019, each PSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive the Merger Consideration (as if the applicable performance conditions were deemed achieved at such levels as described in the Merger Agreement). Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 16:48 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 273 | $127.93 | $34,924.89 |
DisclosureSEC source: 0001131096-18-000197 · wf-form4_153859967934199.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,351 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 7, 2018, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.83 to $128.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). F4 · balance_after: Includes 7,189 units of common stock that were granted pursuant to RSU awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 16:48 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 1,931 | $127.13 | $245,488.03 |
DisclosureSEC source: 0001131096-18-000197 · wf-form4_153859967934199.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,624 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 7, 2018, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.83 to $127.78, inclusive. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 16:48 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 921 | $133.60 | $123,045.60 |
DisclosureSEC source: 0001131096-18-000197 · wf-form4_153859967934199.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,555 Read SEC document |
| May 16, 2018 Filed May 17, 2018 17:18 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 357 | $150.32 | $53,664.24 |
DisclosureSEC source: 0001131096-18-000122 · wf-form4_152659189455980.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,476 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 7, 2018, in accordance with Rule 10b5-1. F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.06 to $150.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). F5 · balance_after: Includes 10,314 units of common stock that were granted pursuant to RSU awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock. Read SEC document |
| May 16, 2018 Filed May 17, 2018 17:18 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 550 | $149.31 | $82,120.50 |
DisclosureSEC source: 0001131096-18-000122 · wf-form4_152659189455980.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,833 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 7, 2018, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.80, inclusive. Read SEC document |
| May 16, 2018 Filed May 17, 2018 17:18 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 200 | $147.99 | $29,598.00 |
DisclosureSEC source: 0001131096-18-000122 · wf-form4_152659189455980.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,383 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 7, 2018, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.56 to $148.42, inclusive. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantStock Option (Right to Buy) · Derivative | 3,690 | $0.00 Strike: $137.49 | $0.00 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · derivative · entry 11 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 3,690 shares Expires 2028-03-01 F6 · derivative.exercise_date: The option award vests in three equal annual installments beginning on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 1,153 | $136.83 | $157,764.99 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 10 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,583 F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.56 to $137.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (4). F5 · balance_after: Includes 10,314 units of common stock that were granted pursuant to RSU awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 9 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,736 F3 · shares: Represents a restricted stock unit ("RSU") award granted under the Issuer's 2007 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The award is subject to time-based vesting and vests in three equal annual installments beginning on March 1, 2019. The RSUs will be settled only in stock. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 107 | $139.74 | $14,952.18 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 8 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,236 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 276 | $139.74 | $38,568.24 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 7 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 77 | $139.74 | $10,759.98 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 6 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,619 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 76 | $139.74 | $10,620.24 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 5 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,696 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 216 | $139.74 | $30,183.84 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 4 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,772 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 732 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,988 F2 · shares: On March 1, 2017, the Reporting Person was granted an award of 6,568 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2018 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2017, 2018 and 2019. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 732 shares on March 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 180 | $139.74 | $25,153.20 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,256 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:41 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 611 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-18-000081 · wf-form4_152028964775099.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,436 F1 · shares: On March 1, 2016, the Reporting Person was granted a Performance Stock Unit ("PSU") award of 5,817 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2017 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2016, 2017 and 2018. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 611 shares on March 1, 2018. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 18:08 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 200 | $123.74 | $24,748.00 |
DisclosureSEC source: 0001131096-17-000164 · wf-form4_150706852388009.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,825 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of November 1, 2016, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.63 to $123.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). F4 · balance_after: Includes 10,635 Restricted Stock Units (each, an "RSU") that are subject to time-based vesting and will be settled only in stock. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 18:08 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 1,383 | $124.68 | $172,432.44 |
DisclosureSEC source: 0001131096-17-000164 · wf-form4_150706852388009.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,025 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of November 1, 2016, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.30 to $125.03, inclusive. Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 18:08 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 1,015 | $124.36 | $126,225.40 |
DisclosureSEC source: 0001131096-17-000164 · wf-form4_150706852388009.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · Chief Legal & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,408 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionPerformance Stock Unit · Derivative | 1,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · derivative · entry 11 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,879 Underlying: Common Stock · 1,549 shares Expires 2019-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Issuer's common stock. F10 · derivative.exercise_date: On March 1, 2016, the Reporting Person was granted a performance stock unit ("PSU") award of 5,817 PSUs. The PSUs vest in three equal annual installments beginning on March 1, 2017 based on the Issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016. On February 7, 2017, the Compensation Committee of the Board of Directors of the Issuer certified that the performance criteria for 2016 was met, resulting in vesting of PSUs as to 1,549 shares on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 896 | $118.04 | $105,763.84 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 10 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,423 F5 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of November 1, 2016, in accordance with Rule 10b5-1. F7 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.57 to $118.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (7). F8 · balance_after: 13,760 of these securities are units of common stock granted pursuant to RSU awards. The units are subject to time-based vesting. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 844 | $117.40 | $99,085.60 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 9 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,319 F5 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of November 1, 2016, in accordance with Rule 10b5-1. F6 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.21 to $117.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (6). Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 2,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 8 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,163 F4 · price: The securities acquired are units of common stock that were granted pursuant to a RSU award under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 503 | $117.22 | $58,961.66 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 7 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,604 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionCommon Stock | 1,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 6 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Performance Stock Unit ("PSU") converts into common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 85 | $117.22 | $9,963.70 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 5 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,558 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 305 | $117.22 | $35,752.10 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 4 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,643 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 120 | $117.22 | $14,066.40 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,948 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 105 | $117.22 | $12,308.10 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,068 Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 17:54 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 2,109 | $124.43 | $262,422.87 |
DisclosureSEC source: 0001131096-16-000391 · wf-form4_147561805929481.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70 F3 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2015 in accordance with Rule 10b5-1, which plan was assigned to a different broker on March 1, 2016. F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.04 to $124.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5). Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:54 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionRestricted Stock Unit · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-16-000391 · wf-form4_147561805929481.xml · derivative · entry 4 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 3,125 shares Expires 2019-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: On November 2, 2015, the Reporting Person was granted 12,500 RSUs. The RSUs vest in four equal annual installments beginning on October 1, 2016. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:54 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 1,016 | $126.12 | $128,137.92 |
DisclosureSEC source: 0001131096-16-000391 · wf-form4_147561805929481.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,179 F2 · shares: Shares withheld to satisfy tax withholding obligations incurred upon the vesting of RSUs. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:54 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-16-000391 · wf-form4_147561805929481.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") converts into common stock on a one-for-one basis. Read SEC document |
| September 30, 2016 Filed Mar 3, 2017 21:47 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | OtherCommon Stock | 13 | $107.20 | $1,393.60 |
DisclosureSEC source: 0001131096-17-000044 · wf-form4_148859564797009.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,173 F1 · acquired: Shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on September 30, 2016, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934. F2 · balance_after: Includes 13,090 Restricted Stock Units (each, an "RSU") that are subject to time-based vesting and will be settled only in stock. Of the 13,090 unvested RSUs, 9,375 were previously reported by the Reporting Person as derivative securities, and 3,715 were subject to awards granted to the Reporting Person prior to his designation as a Section 16 officer. Effective March 1, 2017, the Reporting Person has determined to report RSU awards that are subject to time-based vesting and only settled in stock as non-derivative securities in his ownership reports. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 17:01 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-16-000381 · wf-form4_147319565270739.xml · derivative · entry 4 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires 2016-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: On November 1, 2012, the Reporting Person was granted 5,000 RSUs. The RSUs vest in four equal annual installments beginning on September 1, 2013. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 17:01 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | SaleCommon Stock | 843 | $123.18 | $103,840.74 |
DisclosureSEC source: 0001131096-16-000381 · wf-form4_147319565270739.xml · nonDerivative · entry 3 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70 F4 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of March 1, 2016, in accordance with Rule 10b5-1. F5 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.89 to $123.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (5). Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 17:01 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Tax withholdingCommon Stock | 407 | $123.13 | $50,113.91 |
DisclosureSEC source: 0001131096-16-000381 · wf-form4_147319565270739.xml · nonDerivative · entry 2 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913 F3 · shares: Shares withheld to satisfy tax withholding obligations incurred upon the vesting of RSUs. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 17:01 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-16-000381 · wf-form4_147319565270739.xml · nonDerivative · entry 1 Haley Daniel P · CIK 0001653709 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") converts into common stock on a one-for-one basis. F2 · balance_after: Includes 28 shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on April 1, 2016, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.